Imexpharm (STC:IMP) Effect of Exchange Rate Changes: ₫ Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STC:IMP Imexpharm Corp STC:IMP
99 GF Score
Price ₫38,050.00
GF Value ₫55,707.21
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Imexpharm Effect of Exchange Rate Changes?

Imexpharm STC:IMP +3.12% 99 Effect of Exchange Rate Changes is ₫ Mil as of Mar. 2026. GuruFocus rates STC:IMP with a GF Score™ of 99/100 and a GF Value™ of ₫55,707.21 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Imexpharm's Effect of Exchange Rate Changes for the three months ended in Mar. 2026 was ₫ Mil.

Imexpharm's Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Mar. 2026 was ₫ Mil.

Imexpharm Effect of Exchange Rate Changes Related Terms

Imexpharm Effect of Exchange Rate Changes Historical Data

* Premium members only.

The historical data trend for Imexpharm's Effect of Exchange Rate Changes can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imexpharm Effect of Exchange Rate Changes Chart

Imexpharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Effect of Exchange Rate Changes
Get a 7-Day Free Trial Premium Member Only Premium Member Only -230.63 -9.19 -0.59 19.18 -30.66

Imexpharm Quarterly Data
Mar17 Sep17 Dec17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Effect of Exchange Rate Changes Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.00 - 0.00 -
STC:IMP
99GF Score
Imexpharm Corp STC:IMP
Effect of Exchange Rate Changes is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imexpharm Effect of Exchange Rate Changes Calculation

Effect of Exchange Rate Changes represents the effect of exchange rate changes on cash balances held in foreign currencies.

Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Effect of Exchange Rate Changes of ₫ Mil mean?
Imexpharm (STC:IMP) has a Effect of Exchange Rate Changes of ₫ Mil as of Mar. 2026. Effect of Exchange Rate Changes gives the cumulative effect due to foreign exchange rate fluctuations. View historical data for Imexpharm.
Is Imexpharm's Effect of Exchange Rate Changes too high?
Imexpharm's current Effect of Exchange Rate Changes is ₫ Mil. Overall, Imexpharm has a GF Score™ of 99/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imexpharm's Effect of Exchange Rate Changes compare to ZTS?
Imexpharm's Effect of Exchange Rate Changes of ₫ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effect of Exchange Rate Changes for a Drug Manufacturers company?
A good Effect of Exchange Rate Changes depends on the Drug Manufacturers industry context. However, Effect of Exchange Rate Changes should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effect of Exchange Rate Changes mean?
A high Effect of Exchange Rate Changes can signal that a stock is expensive relative to its fundamentals. Effect of Exchange Rate Changes gives the cumulative effect due to foreign exchange rate fluctuations. View historical data for Imexpharm. Imexpharm's current Effect of Exchange Rate Changes is ₫ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imexpharm stock overvalued right now?
Based on GuruFocus' analysis, Imexpharm (STC:IMP) is currently considered Significantly Undervalued. The stock's GF Value™ is ₫55,707.21, compared to a current price of ₫38,050.00 — trading 31.7% below its estimated fair value. The current Effect of Exchange Rate Changes is ₫ Mil. Imexpharm's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effect of Exchange Rate Changes calculated?
Effect of Exchange Rate Changes is calculated from a company's financial statements. For Imexpharm (STC:IMP), the current Effect of Exchange Rate Changes is ₫ Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imexpharm (STC:IMP) Overvalued in 2026?

Based on GuruFocus' analysis, Imexpharm stock appears to be undervalued. The current stock price of ₫38,050.00 is trading 31.7% below its estimated GF Value™ of ₫55,707.21. GuruFocus considers Imexpharm to be Significantly Undervalued.

Key valuation signals for STC:IMP:

  • Effect of Exchange Rate Changes: ₫ Mil
  • GF Value™: ₫55,707.21 vs. price of ₫38,050.00 (31.7% below fair value)
  • GF Score™: 99/100 with 1 warning sign

No single metric tells the full story. See the STC:IMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imexpharm Business Description

Address 4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. The company's products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.
99GF Score

Get the complete analysis for STC:IMP

Effect of Exchange Rate Changes is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫38,050.00
Price
₫55,707.21
GF Value